These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 39027900)

  • 1. Unraveling neurovascular mysteries: the role of endothelial glycocalyx dysfunction in Alzheimer's disease pathogenesis.
    O'Hare N; Millican K; Ebong EE
    Front Physiol; 2024; 15():1394725. PubMed ID: 39027900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?
    Kelleher RJ; Soiza RL
    Am J Cardiovasc Dis; 2013 Nov; 3(4):197-226. PubMed ID: 24224133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diosmin and its glycocalyx restorative and anti-inflammatory effects on injured blood vessels.
    Mitra R; Nersesyan A; Pentland K; Melin MM; Levy RM; Ebong EE
    FASEB J; 2022 Dec; 36(12):e22630. PubMed ID: 36315163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycocalyx is critical for blood-brain barrier integrity by suppressing caveolin1-dependent endothelial transcytosis following ischemic stroke.
    Zhu J; Li Z; Ji Z; Wu Y; He Y; Liu K; Chang Y; Peng Y; Lin Z; Wang S; Wang D; Huang K; Pan S
    Brain Pathol; 2022 Jan; 32(1):e13006. PubMed ID: 34286899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial barrier reinforcement relies on flow-regulated glycocalyx, a potential therapeutic target.
    Harding IC; Mitra R; Mensah SA; Nersesyan A; Bal NN; Ebong EE
    Biorheology; 2019; 56(2-3):131-149. PubMed ID: 30988234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target.
    Mitra R; O'Neil GL; Harding IC; Cheng MJ; Mensah SA; Ebong EE
    Curr Atheroscler Rep; 2017 Nov; 19(12):63. PubMed ID: 29127504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Glycocalyx: The Importance of Sugar Coating the Blood-Brain Barrier.
    Dancy C; Heintzelman KE; Katt ME
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39125975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
    Bell RD; Zlokovic BV
    Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease.
    Van Skike CE; Hussong SA; Hernandez SF; Banh AQ; DeRosa N; Galvan V
    J Neurosci; 2021 May; 41(19):4305-4320. PubMed ID: 33888602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.
    Grammas P
    J Neuroinflammation; 2011 Mar; 8():26. PubMed ID: 21439035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain imaging of neurovascular dysfunction in Alzheimer's disease.
    Montagne A; Nation DA; Pa J; Sweeney MD; Toga AW; Zlokovic BV
    Acta Neuropathol; 2016 May; 131(5):687-707. PubMed ID: 27038189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic targets in the neurovascular pathway in Alzheimer's disease.
    Zlokovic BV
    Neurotherapeutics; 2008 Jul; 5(3):409-14. PubMed ID: 18625452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Glycocalyx-Mediated Intercellular Interactions: Mechanisms and Implications for Atherosclerosis and Cancer Metastasis.
    Mensah SA; Nersesyan AA; Ebong EE
    Cardiovasc Eng Technol; 2021 Feb; 12(1):72-90. PubMed ID: 33000443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The temporal response and mechanism of action of tranexamic acid in endothelial glycocalyx degradation.
    Diebel ME; Martin JV; Liberati DM; Diebel LN
    J Trauma Acute Care Surg; 2018 Jan; 84(1):75-80. PubMed ID: 29040203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered 3D human neurovascular model of Alzheimer's disease to study vascular dysfunction.
    Pavlou G; Spitz S; Pramotton FM; Tsai A; Li BM; Wang X; Barr OM; Ko EC; Zhang S; Ashley SJ; Maaser-Hecker A; Choi SH; Jorfi M; Tanzi RE; Kamm RD
    Biomaterials; 2025 Mar; 314():122864. PubMed ID: 39357152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Behavior of the Endothelial Glycocalyx Is Associated With Pathophysiologic Status in Septic Mice: An Integrated Approach to Analyzing the Behavior and Function of the Glycocalyx Using Both Electron and Fluorescence Intravital Microscopy.
    Kataoka H; Ushiyama A; Akimoto Y; Matsubara S; Kawakami H; Iijima T
    Anesth Analg; 2017 Sep; 125(3):874-883. PubMed ID: 28504989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Intravenous Nanoparticle Delivery: Role of Flow and Endothelial Glycocalyx Integrity.
    Cheng MJ; Mitra R; Okorafor CC; Nersesyan AA; Harding IC; Bal NN; Kumar R; Jo H; Sridhar S; Ebong EE
    Ann Biomed Eng; 2020 Jul; 48(7):1941-1954. PubMed ID: 32072383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review.
    Van Skike CE; Galvan V
    Gerontology; 2018; 64(3):205-211. PubMed ID: 29320772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural stem cell therapy for neurovascular injury in Alzheimer's disease.
    Boese AC; Hamblin MH; Lee JP
    Exp Neurol; 2020 Feb; 324():113112. PubMed ID: 31730762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared Molecular Mechanisms among Alzheimer's Disease, Neurovascular Unit Dysfunction and Vascular Risk Factors: A Narrative Review.
    Falsetti L; Viticchi G; Zaccone V; Guerrieri E; Moroncini G; Luzzi S; Silvestrini M
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.